Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
CapEx to Revenue
4.92%
Quarterly · Period ending:
BIO CapEx to Revenue
Latest reported4.92%period ending
Latest reported4.92%period ending
BIO Quarterly CapEx/Revenue (0.00% → 4.92%)
Latest values, visible window
High-resolution chart · PNG
BIO capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 5.3098% | |
| 4.5779% | |
| 4.0787% | |
| 3.9544% | |
| 4.7216% | |
| 4.5284% | |
| 108.0761% | |
| 7.9295% | |
| 5.5268% | |
| 3.6595% | |
| 5.7239% | |
| 6.2626% | |
| 3.7071% | |
| 3.6145% | |
| 33.4197% | |
| 7.0352% | |
| 4.0643% | |
| 4.5326% | |
| 4.2982% | |
| 4.1408% | |
| 3.7% | |
| 2.4007% | |
| 3.0584% | |
| 3.2293% | |
| 3.3708% | |
| 2.7579% | |
| 3.7229% | |
| 2.9833% | |
| 2.3502% | |
| 1.8952% | |
| 3.551% | |
| 3.0418% | |
| 5.7457% | |
| 5.3416% | |
| 5.3348% | |
| 7.7608% | |
| 6.25% | |
| 5.5024% | |
| 10.0728% | |
| 10.6525% | |
| 11.8954% | |
| 7.3012% | |
| 6.2267% | |
| 4.1727% | |
| 4.7965% | |
| 3.2305% | |
| 7.716% | |
| 5.9891% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |